Work

Efficacy and safety of gefitinib and potential prognostic value of soluble EGFR, EGFR mutations, and tumor markers in a Gynecologic Oncology Group phase II trial of persistent or recurrent endometrial cancer

Year: 2009

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2009.27.15_suppl.e16542

Authors: K. K. Leslie, M. W. Sill, K. M. Darcy, A. T. Baron, J. A. Wilken, A. K. Godwin, L. Cook, R. J. Schilder, J. M. Schilder, N. J. Maihle

Institutions: Fox Chase Cancer Center, University of Kentucky, University of New Mexico, Yale University

Language: English

Topic: Endometrial and Cervical Cancer Treatments

Subfield: Obstetrics and Gynecology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2565616685

Cites:

Cited by: 19

Related to: 10